nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilostazol—CYP3A7—Sorafenib—liver cancer	0.126	0.195	CbGbCtD
Cilostazol—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.126	0.195	CbGbCtD
Cilostazol—CYP3A5—Sorafenib—liver cancer	0.0946	0.146	CbGbCtD
Cilostazol—CYP2C19—Sorafenib—liver cancer	0.0763	0.118	CbGbCtD
Cilostazol—CYP1A2—Sorafenib—liver cancer	0.0704	0.109	CbGbCtD
Cilostazol—CYP2D6—Sorafenib—liver cancer	0.058	0.0898	CbGbCtD
Cilostazol—CYP3A4—Sorafenib—liver cancer	0.0369	0.0571	CbGbCtD
Cilostazol—CYP2D6—Doxorubicin—liver cancer	0.0352	0.0545	CbGbCtD
Cilostazol—CYP3A4—Doxorubicin—liver cancer	0.0224	0.0346	CbGbCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000896	0.00366	CcSEcCtD
Cilostazol—Ventricular tachycardia—Epirubicin—liver cancer	0.000896	0.00366	CcSEcCtD
Cilostazol—Vaginal inflammation—Epirubicin—liver cancer	0.000896	0.00366	CcSEcCtD
Cilostazol—Hyperuricaemia—Doxorubicin—liver cancer	0.000893	0.00365	CcSEcCtD
Cilostazol—Cystitis noninfective—Epirubicin—liver cancer	0.000875	0.00357	CcSEcCtD
Cilostazol—Melaena—Epirubicin—liver cancer	0.000875	0.00357	CcSEcCtD
Cilostazol—Creatinine increased—Doxorubicin—liver cancer	0.000871	0.00355	CcSEcCtD
Cilostazol—Bone pain—Doxorubicin—liver cancer	0.000865	0.00353	CcSEcCtD
Cilostazol—Cystitis—Epirubicin—liver cancer	0.000865	0.00353	CcSEcCtD
Cilostazol—Colitis—Epirubicin—liver cancer	0.00086	0.00351	CcSEcCtD
Cilostazol—Infection—Sorafenib—liver cancer	0.000859	0.00351	CcSEcCtD
Cilostazol—Shock—Sorafenib—liver cancer	0.000851	0.00347	CcSEcCtD
Cilostazol—Fluid retention—Epirubicin—liver cancer	0.00085	0.00347	CcSEcCtD
Cilostazol—Nervous system disorder—Sorafenib—liver cancer	0.000848	0.00346	CcSEcCtD
Cilostazol—Thrombocytopenia—Sorafenib—liver cancer	0.000847	0.00346	CcSEcCtD
Cilostazol—Blood urea increased—Epirubicin—liver cancer	0.000846	0.00345	CcSEcCtD
Cilostazol—Vaginal infection—Epirubicin—liver cancer	0.000846	0.00345	CcSEcCtD
Cilostazol—Blood uric acid increased—Doxorubicin—liver cancer	0.000844	0.00344	CcSEcCtD
Cilostazol—Aplastic anaemia—Epirubicin—liver cancer	0.000841	0.00343	CcSEcCtD
Cilostazol—Skin disorder—Sorafenib—liver cancer	0.00084	0.00343	CcSEcCtD
Cilostazol—Ventricular tachycardia—Doxorubicin—liver cancer	0.000829	0.00338	CcSEcCtD
Cilostazol—Vaginal inflammation—Doxorubicin—liver cancer	0.000829	0.00338	CcSEcCtD
Cilostazol—Anorexia—Sorafenib—liver cancer	0.000824	0.00336	CcSEcCtD
Cilostazol—Cramps of lower extremities—Epirubicin—liver cancer	0.000823	0.00336	CcSEcCtD
Cilostazol—Oesophagitis—Epirubicin—liver cancer	0.000818	0.00334	CcSEcCtD
Cilostazol—Ecchymosis—Epirubicin—liver cancer	0.00081	0.00331	CcSEcCtD
Cilostazol—Bladder pain—Epirubicin—liver cancer	0.00081	0.00331	CcSEcCtD
Cilostazol—Cystitis noninfective—Doxorubicin—liver cancer	0.00081	0.0033	CcSEcCtD
Cilostazol—Melaena—Doxorubicin—liver cancer	0.00081	0.0033	CcSEcCtD
Cilostazol—Cystitis—Doxorubicin—liver cancer	0.0008	0.00327	CcSEcCtD
Cilostazol—Colitis—Doxorubicin—liver cancer	0.000796	0.00325	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000788	0.00322	CcSEcCtD
Cilostazol—Fluid retention—Doxorubicin—liver cancer	0.000787	0.00321	CcSEcCtD
Cilostazol—Blood urea increased—Doxorubicin—liver cancer	0.000782	0.00319	CcSEcCtD
Cilostazol—Vaginal infection—Doxorubicin—liver cancer	0.000782	0.00319	CcSEcCtD
Cilostazol—Aplastic anaemia—Doxorubicin—liver cancer	0.000778	0.00318	CcSEcCtD
Cilostazol—Dyspnoea—Sorafenib—liver cancer	0.000771	0.00315	CcSEcCtD
Cilostazol—Cramps of lower extremities—Doxorubicin—liver cancer	0.000761	0.00311	CcSEcCtD
Cilostazol—Dyspepsia—Sorafenib—liver cancer	0.000761	0.00311	CcSEcCtD
Cilostazol—Oesophagitis—Doxorubicin—liver cancer	0.000757	0.00309	CcSEcCtD
Cilostazol—Decreased appetite—Sorafenib—liver cancer	0.000752	0.00307	CcSEcCtD
Cilostazol—Ecchymosis—Doxorubicin—liver cancer	0.000749	0.00306	CcSEcCtD
Cilostazol—Bladder pain—Doxorubicin—liver cancer	0.000749	0.00306	CcSEcCtD
Cilostazol—Diabetes mellitus—Epirubicin—liver cancer	0.000748	0.00305	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Sorafenib—liver cancer	0.000747	0.00305	CcSEcCtD
Cilostazol—Hepatic function abnormal—Epirubicin—liver cancer	0.000744	0.00304	CcSEcCtD
Cilostazol—Pain—Sorafenib—liver cancer	0.000739	0.00302	CcSEcCtD
Cilostazol—Vascular purpura—Epirubicin—liver cancer	0.000727	0.00297	CcSEcCtD
Cilostazol—Cardiac failure congestive—Epirubicin—liver cancer	0.000717	0.00293	CcSEcCtD
Cilostazol—Gastrointestinal pain—Sorafenib—liver cancer	0.000707	0.00289	CcSEcCtD
Cilostazol—Hot flush—Epirubicin—liver cancer	0.000695	0.00284	CcSEcCtD
Cilostazol—Diabetes mellitus—Doxorubicin—liver cancer	0.000692	0.00282	CcSEcCtD
Cilostazol—Menopausal symptoms—Epirubicin—liver cancer	0.000689	0.00281	CcSEcCtD
Cilostazol—Hepatic function abnormal—Doxorubicin—liver cancer	0.000688	0.00281	CcSEcCtD
Cilostazol—Urticaria—Sorafenib—liver cancer	0.000687	0.0028	CcSEcCtD
Cilostazol—Abdominal pain—Sorafenib—liver cancer	0.000684	0.00279	CcSEcCtD
Cilostazol—Body temperature increased—Sorafenib—liver cancer	0.000684	0.00279	CcSEcCtD
Cilostazol—Purpura—Epirubicin—liver cancer	0.000675	0.00275	CcSEcCtD
Cilostazol—Vascular purpura—Doxorubicin—liver cancer	0.000673	0.00274	CcSEcCtD
Cilostazol—Cardiac failure—Epirubicin—liver cancer	0.000666	0.00272	CcSEcCtD
Cilostazol—Cerebrovascular accident—Epirubicin—liver cancer	0.000664	0.00271	CcSEcCtD
Cilostazol—Cardiac failure congestive—Doxorubicin—liver cancer	0.000663	0.00271	CcSEcCtD
Cilostazol—Diplopia—Epirubicin—liver cancer	0.00065	0.00265	CcSEcCtD
Cilostazol—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.00065	0.00265	CcSEcCtD
Cilostazol—Hot flush—Doxorubicin—liver cancer	0.000643	0.00262	CcSEcCtD
Cilostazol—Menopausal symptoms—Doxorubicin—liver cancer	0.000638	0.0026	CcSEcCtD
Cilostazol—Face oedema—Epirubicin—liver cancer	0.000628	0.00256	CcSEcCtD
Cilostazol—Purpura—Doxorubicin—liver cancer	0.000624	0.00255	CcSEcCtD
Cilostazol—Asthenia—Sorafenib—liver cancer	0.00062	0.00253	CcSEcCtD
Cilostazol—Cardiac arrest—Epirubicin—liver cancer	0.000618	0.00252	CcSEcCtD
Cilostazol—Cardiac failure—Doxorubicin—liver cancer	0.000616	0.00252	CcSEcCtD
Cilostazol—Cerebrovascular accident—Doxorubicin—liver cancer	0.000614	0.00251	CcSEcCtD
Cilostazol—Pruritus—Sorafenib—liver cancer	0.000612	0.0025	CcSEcCtD
Cilostazol—Blood creatinine increased—Epirubicin—liver cancer	0.000609	0.00249	CcSEcCtD
Cilostazol—Diplopia—Doxorubicin—liver cancer	0.000602	0.00246	CcSEcCtD
Cilostazol—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.000602	0.00246	CcSEcCtD
Cilostazol—Liver function test abnormal—Epirubicin—liver cancer	0.0006	0.00245	CcSEcCtD
Cilostazol—Dry skin—Epirubicin—liver cancer	0.000596	0.00243	CcSEcCtD
Cilostazol—Orthostatic hypotension—Epirubicin—liver cancer	0.000594	0.00242	CcSEcCtD
Cilostazol—Diarrhoea—Sorafenib—liver cancer	0.000592	0.00241	CcSEcCtD
Cilostazol—Face oedema—Doxorubicin—liver cancer	0.000581	0.00237	CcSEcCtD
Cilostazol—Gastritis—Epirubicin—liver cancer	0.000575	0.00235	CcSEcCtD
Cilostazol—Cardiac arrest—Doxorubicin—liver cancer	0.000572	0.00233	CcSEcCtD
Cilostazol—Dizziness—Sorafenib—liver cancer	0.000572	0.00233	CcSEcCtD
Cilostazol—Blood creatinine increased—Doxorubicin—liver cancer	0.000564	0.0023	CcSEcCtD
Cilostazol—Asthma—Epirubicin—liver cancer	0.000562	0.00229	CcSEcCtD
Cilostazol—Influenza—Epirubicin—liver cancer	0.000562	0.00229	CcSEcCtD
Cilostazol—Liver function test abnormal—Doxorubicin—liver cancer	0.000555	0.00227	CcSEcCtD
Cilostazol—Dry skin—Doxorubicin—liver cancer	0.000551	0.00225	CcSEcCtD
Cilostazol—Vomiting—Sorafenib—liver cancer	0.00055	0.00224	CcSEcCtD
Cilostazol—Orthostatic hypotension—Doxorubicin—liver cancer	0.000549	0.00224	CcSEcCtD
Cilostazol—Angina pectoris—Epirubicin—liver cancer	0.000547	0.00223	CcSEcCtD
Cilostazol—Rash—Sorafenib—liver cancer	0.000545	0.00223	CcSEcCtD
Cilostazol—Dermatitis—Sorafenib—liver cancer	0.000545	0.00222	CcSEcCtD
Cilostazol—Headache—Sorafenib—liver cancer	0.000542	0.00221	CcSEcCtD
Cilostazol—Bronchitis—Epirubicin—liver cancer	0.00054	0.00221	CcSEcCtD
Cilostazol—Pancytopenia—Epirubicin—liver cancer	0.000534	0.00218	CcSEcCtD
Cilostazol—Gastritis—Doxorubicin—liver cancer	0.000532	0.00217	CcSEcCtD
Cilostazol—Asthma—Doxorubicin—liver cancer	0.00052	0.00212	CcSEcCtD
Cilostazol—Influenza—Doxorubicin—liver cancer	0.00052	0.00212	CcSEcCtD
Cilostazol—Pollakiuria—Epirubicin—liver cancer	0.000519	0.00212	CcSEcCtD
Cilostazol—Nausea—Sorafenib—liver cancer	0.000514	0.0021	CcSEcCtD
Cilostazol—Angina pectoris—Doxorubicin—liver cancer	0.000507	0.00207	CcSEcCtD
Cilostazol—Pneumonia—Epirubicin—liver cancer	0.000504	0.00206	CcSEcCtD
Cilostazol—Bronchitis—Doxorubicin—liver cancer	0.0005	0.00204	CcSEcCtD
Cilostazol—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000497	0.00203	CcSEcCtD
Cilostazol—Pancytopenia—Doxorubicin—liver cancer	0.000494	0.00202	CcSEcCtD
Cilostazol—Jaundice—Epirubicin—liver cancer	0.000488	0.00199	CcSEcCtD
Cilostazol—Conjunctivitis—Epirubicin—liver cancer	0.000487	0.00199	CcSEcCtD
Cilostazol—Urinary tract infection—Epirubicin—liver cancer	0.000487	0.00199	CcSEcCtD
Cilostazol—Pollakiuria—Doxorubicin—liver cancer	0.00048	0.00196	CcSEcCtD
Cilostazol—Haematuria—Epirubicin—liver cancer	0.000478	0.00195	CcSEcCtD
Cilostazol—Hepatobiliary disease—Epirubicin—liver cancer	0.000474	0.00193	CcSEcCtD
Cilostazol—Epistaxis—Epirubicin—liver cancer	0.000473	0.00193	CcSEcCtD
Cilostazol—Sinusitis—Epirubicin—liver cancer	0.00047	0.00192	CcSEcCtD
Cilostazol—Agranulocytosis—Epirubicin—liver cancer	0.000468	0.00191	CcSEcCtD
Cilostazol—Pneumonia—Doxorubicin—liver cancer	0.000466	0.0019	CcSEcCtD
Cilostazol—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00046	0.00188	CcSEcCtD
Cilostazol—Haemoglobin—Epirubicin—liver cancer	0.000452	0.00185	CcSEcCtD
Cilostazol—Jaundice—Doxorubicin—liver cancer	0.000452	0.00184	CcSEcCtD
Cilostazol—Rhinitis—Epirubicin—liver cancer	0.000451	0.00184	CcSEcCtD
Cilostazol—Conjunctivitis—Doxorubicin—liver cancer	0.000451	0.00184	CcSEcCtD
Cilostazol—Urinary tract infection—Doxorubicin—liver cancer	0.000451	0.00184	CcSEcCtD
Cilostazol—Haemorrhage—Epirubicin—liver cancer	0.00045	0.00184	CcSEcCtD
Cilostazol—Hypoaesthesia—Epirubicin—liver cancer	0.000448	0.00183	CcSEcCtD
Cilostazol—Pharyngitis—Epirubicin—liver cancer	0.000446	0.00182	CcSEcCtD
Cilostazol—Oedema peripheral—Epirubicin—liver cancer	0.000443	0.00181	CcSEcCtD
Cilostazol—Haematuria—Doxorubicin—liver cancer	0.000442	0.0018	CcSEcCtD
Cilostazol—Hepatobiliary disease—Doxorubicin—liver cancer	0.000438	0.00179	CcSEcCtD
Cilostazol—Epistaxis—Doxorubicin—liver cancer	0.000437	0.00178	CcSEcCtD
Cilostazol—Sinusitis—Doxorubicin—liver cancer	0.000435	0.00178	CcSEcCtD
Cilostazol—Agranulocytosis—Doxorubicin—liver cancer	0.000433	0.00177	CcSEcCtD
Cilostazol—Erythema multiforme—Epirubicin—liver cancer	0.000425	0.00174	CcSEcCtD
Cilostazol—Tinnitus—Epirubicin—liver cancer	0.000419	0.00171	CcSEcCtD
Cilostazol—Haemoglobin—Doxorubicin—liver cancer	0.000418	0.00171	CcSEcCtD
Cilostazol—Cardiac disorder—Epirubicin—liver cancer	0.000417	0.0017	CcSEcCtD
Cilostazol—Rhinitis—Doxorubicin—liver cancer	0.000417	0.0017	CcSEcCtD
Cilostazol—Haemorrhage—Doxorubicin—liver cancer	0.000416	0.0017	CcSEcCtD
Cilostazol—Hypoaesthesia—Doxorubicin—liver cancer	0.000414	0.00169	CcSEcCtD
Cilostazol—Pharyngitis—Doxorubicin—liver cancer	0.000413	0.00169	CcSEcCtD
Cilostazol—Oedema peripheral—Doxorubicin—liver cancer	0.00041	0.00167	CcSEcCtD
Cilostazol—Angiopathy—Epirubicin—liver cancer	0.000408	0.00167	CcSEcCtD
Cilostazol—Mediastinal disorder—Epirubicin—liver cancer	0.000405	0.00165	CcSEcCtD
Cilostazol—Chills—Epirubicin—liver cancer	0.000404	0.00165	CcSEcCtD
Cilostazol—Erythema multiforme—Doxorubicin—liver cancer	0.000394	0.00161	CcSEcCtD
Cilostazol—Tinnitus—Doxorubicin—liver cancer	0.000388	0.00158	CcSEcCtD
Cilostazol—Cardiac disorder—Doxorubicin—liver cancer	0.000386	0.00158	CcSEcCtD
Cilostazol—Flatulence—Epirubicin—liver cancer	0.000386	0.00157	CcSEcCtD
Cilostazol—Back pain—Epirubicin—liver cancer	0.000379	0.00155	CcSEcCtD
Cilostazol—Angiopathy—Doxorubicin—liver cancer	0.000378	0.00154	CcSEcCtD
Cilostazol—Muscle spasms—Epirubicin—liver cancer	0.000376	0.00154	CcSEcCtD
Cilostazol—Mediastinal disorder—Doxorubicin—liver cancer	0.000375	0.00153	CcSEcCtD
Cilostazol—Chills—Doxorubicin—liver cancer	0.000373	0.00152	CcSEcCtD
Cilostazol—Ill-defined disorder—Epirubicin—liver cancer	0.000363	0.00148	CcSEcCtD
Cilostazol—Anaemia—Epirubicin—liver cancer	0.000362	0.00148	CcSEcCtD
Cilostazol—Flatulence—Doxorubicin—liver cancer	0.000357	0.00146	CcSEcCtD
Cilostazol—Malaise—Epirubicin—liver cancer	0.000353	0.00144	CcSEcCtD
Cilostazol—Vertigo—Epirubicin—liver cancer	0.000352	0.00144	CcSEcCtD
Cilostazol—Syncope—Epirubicin—liver cancer	0.000351	0.00143	CcSEcCtD
Cilostazol—Leukopenia—Epirubicin—liver cancer	0.000351	0.00143	CcSEcCtD
Cilostazol—Back pain—Doxorubicin—liver cancer	0.00035	0.00143	CcSEcCtD
Cilostazol—Muscle spasms—Doxorubicin—liver cancer	0.000348	0.00142	CcSEcCtD
Cilostazol—Palpitations—Epirubicin—liver cancer	0.000346	0.00141	CcSEcCtD
Cilostazol—Loss of consciousness—Epirubicin—liver cancer	0.000344	0.0014	CcSEcCtD
Cilostazol—Cough—Epirubicin—liver cancer	0.000342	0.00139	CcSEcCtD
Cilostazol—Hypertension—Epirubicin—liver cancer	0.000338	0.00138	CcSEcCtD
Cilostazol—Ill-defined disorder—Doxorubicin—liver cancer	0.000336	0.00137	CcSEcCtD
Cilostazol—Anaemia—Doxorubicin—liver cancer	0.000335	0.00137	CcSEcCtD
Cilostazol—Myalgia—Epirubicin—liver cancer	0.000333	0.00136	CcSEcCtD
Cilostazol—Chest pain—Epirubicin—liver cancer	0.000333	0.00136	CcSEcCtD
Cilostazol—Arthralgia—Epirubicin—liver cancer	0.000333	0.00136	CcSEcCtD
Cilostazol—Anxiety—Epirubicin—liver cancer	0.000332	0.00136	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000331	0.00135	CcSEcCtD
Cilostazol—Discomfort—Epirubicin—liver cancer	0.000329	0.00134	CcSEcCtD
Cilostazol—Malaise—Doxorubicin—liver cancer	0.000327	0.00133	CcSEcCtD
Cilostazol—Vertigo—Doxorubicin—liver cancer	0.000326	0.00133	CcSEcCtD
Cilostazol—Syncope—Doxorubicin—liver cancer	0.000325	0.00133	CcSEcCtD
Cilostazol—Leukopenia—Doxorubicin—liver cancer	0.000324	0.00132	CcSEcCtD
Cilostazol—Palpitations—Doxorubicin—liver cancer	0.00032	0.00131	CcSEcCtD
Cilostazol—Oedema—Epirubicin—liver cancer	0.00032	0.0013	CcSEcCtD
Cilostazol—Loss of consciousness—Doxorubicin—liver cancer	0.000318	0.0013	CcSEcCtD
Cilostazol—Infection—Epirubicin—liver cancer	0.000317	0.0013	CcSEcCtD
Cilostazol—Cough—Doxorubicin—liver cancer	0.000316	0.00129	CcSEcCtD
Cilostazol—Shock—Epirubicin—liver cancer	0.000314	0.00128	CcSEcCtD
Cilostazol—Nervous system disorder—Epirubicin—liver cancer	0.000313	0.00128	CcSEcCtD
Cilostazol—Thrombocytopenia—Epirubicin—liver cancer	0.000313	0.00128	CcSEcCtD
Cilostazol—Hypertension—Doxorubicin—liver cancer	0.000313	0.00128	CcSEcCtD
Cilostazol—Tachycardia—Epirubicin—liver cancer	0.000312	0.00127	CcSEcCtD
Cilostazol—Skin disorder—Epirubicin—liver cancer	0.00031	0.00127	CcSEcCtD
Cilostazol—Myalgia—Doxorubicin—liver cancer	0.000308	0.00126	CcSEcCtD
Cilostazol—Chest pain—Doxorubicin—liver cancer	0.000308	0.00126	CcSEcCtD
Cilostazol—Arthralgia—Doxorubicin—liver cancer	0.000308	0.00126	CcSEcCtD
Cilostazol—Anxiety—Doxorubicin—liver cancer	0.000307	0.00125	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000306	0.00125	CcSEcCtD
Cilostazol—Discomfort—Doxorubicin—liver cancer	0.000305	0.00124	CcSEcCtD
Cilostazol—Anorexia—Epirubicin—liver cancer	0.000305	0.00124	CcSEcCtD
Cilostazol—Hypotension—Epirubicin—liver cancer	0.000299	0.00122	CcSEcCtD
Cilostazol—Oedema—Doxorubicin—liver cancer	0.000296	0.00121	CcSEcCtD
Cilostazol—Infection—Doxorubicin—liver cancer	0.000294	0.0012	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000291	0.00119	CcSEcCtD
Cilostazol—Shock—Doxorubicin—liver cancer	0.000291	0.00119	CcSEcCtD
Cilostazol—Nervous system disorder—Doxorubicin—liver cancer	0.00029	0.00118	CcSEcCtD
Cilostazol—Thrombocytopenia—Doxorubicin—liver cancer	0.00029	0.00118	CcSEcCtD
Cilostazol—Insomnia—Epirubicin—liver cancer	0.000289	0.00118	CcSEcCtD
Cilostazol—Tachycardia—Doxorubicin—liver cancer	0.000289	0.00118	CcSEcCtD
Cilostazol—Skin disorder—Doxorubicin—liver cancer	0.000287	0.00117	CcSEcCtD
Cilostazol—Paraesthesia—Epirubicin—liver cancer	0.000287	0.00117	CcSEcCtD
Cilostazol—Dyspnoea—Epirubicin—liver cancer	0.000285	0.00116	CcSEcCtD
Cilostazol—Anorexia—Doxorubicin—liver cancer	0.000282	0.00115	CcSEcCtD
Cilostazol—Dyspepsia—Epirubicin—liver cancer	0.000281	0.00115	CcSEcCtD
Cilostazol—Decreased appetite—Epirubicin—liver cancer	0.000278	0.00113	CcSEcCtD
Cilostazol—Hypotension—Doxorubicin—liver cancer	0.000276	0.00113	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Epirubicin—liver cancer	0.000276	0.00113	CcSEcCtD
Cilostazol—Pain—Epirubicin—liver cancer	0.000273	0.00112	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000269	0.0011	CcSEcCtD
Cilostazol—Insomnia—Doxorubicin—liver cancer	0.000267	0.00109	CcSEcCtD
Cilostazol—Paraesthesia—Doxorubicin—liver cancer	0.000266	0.00108	CcSEcCtD
Cilostazol—Dyspnoea—Doxorubicin—liver cancer	0.000264	0.00108	CcSEcCtD
Cilostazol—Feeling abnormal—Epirubicin—liver cancer	0.000263	0.00107	CcSEcCtD
Cilostazol—Gastrointestinal pain—Epirubicin—liver cancer	0.000261	0.00107	CcSEcCtD
Cilostazol—Dyspepsia—Doxorubicin—liver cancer	0.00026	0.00106	CcSEcCtD
Cilostazol—Decreased appetite—Doxorubicin—liver cancer	0.000257	0.00105	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000255	0.00104	CcSEcCtD
Cilostazol—Urticaria—Epirubicin—liver cancer	0.000254	0.00104	CcSEcCtD
Cilostazol—Pain—Doxorubicin—liver cancer	0.000253	0.00103	CcSEcCtD
Cilostazol—Body temperature increased—Epirubicin—liver cancer	0.000253	0.00103	CcSEcCtD
Cilostazol—Abdominal pain—Epirubicin—liver cancer	0.000253	0.00103	CcSEcCtD
Cilostazol—Feeling abnormal—Doxorubicin—liver cancer	0.000244	0.000994	CcSEcCtD
Cilostazol—Gastrointestinal pain—Doxorubicin—liver cancer	0.000242	0.000987	CcSEcCtD
Cilostazol—Urticaria—Doxorubicin—liver cancer	0.000235	0.000959	CcSEcCtD
Cilostazol—Abdominal pain—Doxorubicin—liver cancer	0.000234	0.000954	CcSEcCtD
Cilostazol—Body temperature increased—Doxorubicin—liver cancer	0.000234	0.000954	CcSEcCtD
Cilostazol—Asthenia—Epirubicin—liver cancer	0.000229	0.000936	CcSEcCtD
Cilostazol—Pruritus—Epirubicin—liver cancer	0.000226	0.000923	CcSEcCtD
Cilostazol—Diarrhoea—Epirubicin—liver cancer	0.000219	0.000892	CcSEcCtD
Cilostazol—Asthenia—Doxorubicin—liver cancer	0.000212	0.000866	CcSEcCtD
Cilostazol—Dizziness—Epirubicin—liver cancer	0.000211	0.000862	CcSEcCtD
Cilostazol—Pruritus—Doxorubicin—liver cancer	0.000209	0.000854	CcSEcCtD
Cilostazol—Vomiting—Epirubicin—liver cancer	0.000203	0.000829	CcSEcCtD
Cilostazol—Diarrhoea—Doxorubicin—liver cancer	0.000202	0.000826	CcSEcCtD
Cilostazol—Rash—Epirubicin—liver cancer	0.000201	0.000822	CcSEcCtD
Cilostazol—Dermatitis—Epirubicin—liver cancer	0.000201	0.000822	CcSEcCtD
Cilostazol—Headache—Epirubicin—liver cancer	0.0002	0.000817	CcSEcCtD
Cilostazol—Dizziness—Doxorubicin—liver cancer	0.000196	0.000798	CcSEcCtD
Cilostazol—Nausea—Epirubicin—liver cancer	0.00019	0.000775	CcSEcCtD
Cilostazol—Vomiting—Doxorubicin—liver cancer	0.000188	0.000767	CcSEcCtD
Cilostazol—Rash—Doxorubicin—liver cancer	0.000186	0.000761	CcSEcCtD
Cilostazol—Dermatitis—Doxorubicin—liver cancer	0.000186	0.00076	CcSEcCtD
Cilostazol—Headache—Doxorubicin—liver cancer	0.000185	0.000756	CcSEcCtD
Cilostazol—Nausea—Doxorubicin—liver cancer	0.000176	0.000717	CcSEcCtD
Cilostazol—CYP3A5—Metabolism—GLUL—liver cancer	5.06e-05	0.000465	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	5.05e-05	0.000463	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—PIK3CA—liver cancer	5.03e-05	0.000462	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—UGDH—liver cancer	5.03e-05	0.000462	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—NR1H4—liver cancer	4.88e-05	0.000448	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—TP53—liver cancer	4.87e-05	0.000447	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CSF2—liver cancer	4.86e-05	0.000447	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—RAF1—liver cancer	4.85e-05	0.000446	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GSTA3—liver cancer	4.8e-05	0.000441	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—H2AFX—liver cancer	4.79e-05	0.00044	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—IL2—liver cancer	4.79e-05	0.00044	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—PIK3CB—liver cancer	4.74e-05	0.000435	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—EPT1—liver cancer	4.73e-05	0.000434	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—HRAS—liver cancer	4.66e-05	0.000428	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—HPGDS—liver cancer	4.51e-05	0.000414	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—TAT—liver cancer	4.48e-05	0.000412	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	4.41e-05	0.000405	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GSTA4—liver cancer	4.39e-05	0.000403	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—IL2—liver cancer	4.35e-05	0.0004	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—TERT—liver cancer	4.34e-05	0.000398	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GSTA2—liver cancer	4.28e-05	0.000393	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—liver cancer	4.24e-05	0.000389	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GSTA1—liver cancer	4.12e-05	0.000379	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—AKT1—liver cancer	4.11e-05	0.000378	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—NAT2—liver cancer	4.08e-05	0.000375	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PSMA4—liver cancer	4.02e-05	0.000369	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PSMD10—liver cancer	4.02e-05	0.000369	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—KDR—liver cancer	3.97e-05	0.000364	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MAPK14—liver cancer	3.94e-05	0.000362	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GLUL—liver cancer	3.91e-05	0.000359	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CPT1B—liver cancer	3.91e-05	0.000359	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GOT2—liver cancer	3.91e-05	0.000359	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ALDOB—liver cancer	3.91e-05	0.000359	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—UGDH—liver cancer	3.88e-05	0.000357	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—ESR1—liver cancer	3.86e-05	0.000355	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—F2—liver cancer	3.82e-05	0.000351	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—NR1H4—liver cancer	3.77e-05	0.000346	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CRABP1—liver cancer	3.73e-05	0.000343	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTA3—liver cancer	3.71e-05	0.000341	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CYP2E1—liver cancer	3.68e-05	0.000338	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PIK3CG—liver cancer	3.65e-05	0.000335	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—APC—liver cancer	3.65e-05	0.000335	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—EPT1—liver cancer	3.65e-05	0.000335	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CPT1B—liver cancer	3.6e-05	0.00033	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GLUL—liver cancer	3.6e-05	0.00033	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—NR1H4—liver cancer	3.47e-05	0.000319	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—TAT—liver cancer	3.46e-05	0.000318	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CYCS—liver cancer	3.44e-05	0.000316	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—BRAF—liver cancer	3.43e-05	0.000315	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTA3—liver cancer	3.41e-05	0.000313	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTA4—liver cancer	3.39e-05	0.000312	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GGT1—liver cancer	3.38e-05	0.00031	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GOT1—liver cancer	3.38e-05	0.00031	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.32e-05	0.000304	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTA2—liver cancer	3.31e-05	0.000304	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	3.3e-05	0.000303	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—HPGDS—liver cancer	3.26e-05	0.000299	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PIK3CD—liver cancer	3.21e-05	0.000295	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTA1—liver cancer	3.19e-05	0.000293	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—PIK3CA—liver cancer	3.18e-05	0.000292	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—SERPINE1—liver cancer	3.18e-05	0.000292	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—NAT2—liver cancer	3.15e-05	0.00029	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—KRAS—liver cancer	3.14e-05	0.000289	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTA4—liver cancer	3.12e-05	0.000287	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CPT1B—liver cancer	3.05e-05	0.00028	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GLUL—liver cancer	3.05e-05	0.00028	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTA2—liver cancer	3.04e-05	0.000279	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GSTP1—liver cancer	3.03e-05	0.000279	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	3.03e-05	0.000278	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ALDOB—liver cancer	3.02e-05	0.000278	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—HMOX1—liver cancer	2.99e-05	0.000275	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NR1H4—liver cancer	2.94e-05	0.00027	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTA1—liver cancer	2.93e-05	0.000269	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PSMA4—liver cancer	2.91e-05	0.000267	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PSMD10—liver cancer	2.91e-05	0.000267	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—NAT2—liver cancer	2.9e-05	0.000266	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTA3—liver cancer	2.89e-05	0.000265	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—PIK3CA—liver cancer	2.89e-05	0.000265	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CRABP1—liver cancer	2.88e-05	0.000265	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—RAF1—liver cancer	2.87e-05	0.000263	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GOT2—liver cancer	2.83e-05	0.00026	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MTOR—liver cancer	2.8e-05	0.000257	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PIK3CB—liver cancer	2.8e-05	0.000257	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GSTM1—liver cancer	2.79e-05	0.000256	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ALDOB—liver cancer	2.78e-05	0.000255	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—HRAS—liver cancer	2.67e-05	0.000245	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CYP2E1—liver cancer	2.66e-05	0.000244	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CRABP1—liver cancer	2.65e-05	0.000244	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTA4—liver cancer	2.64e-05	0.000243	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CYP1A1—liver cancer	2.64e-05	0.000243	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CDKN1B—liver cancer	2.63e-05	0.000241	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—AKT1—liver cancer	2.6e-05	0.000239	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.6e-05	0.000238	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.58e-05	0.000237	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTA2—liver cancer	2.58e-05	0.000237	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CASP3—liver cancer	2.57e-05	0.000236	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—IL2—liver cancer	2.57e-05	0.000236	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—IL6—liver cancer	2.56e-05	0.000235	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—HPGDS—liver cancer	2.52e-05	0.000232	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.51e-05	0.00023	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CCND1—liver cancer	2.51e-05	0.00023	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—JUN—liver cancer	2.5e-05	0.00023	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CYCS—liver cancer	2.49e-05	0.000228	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTA1—liver cancer	2.48e-05	0.000228	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CTNNB1—liver cancer	2.48e-05	0.000228	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—MTHFR—liver cancer	2.46e-05	0.000226	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NAT2—liver cancer	2.46e-05	0.000226	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GGT1—liver cancer	2.44e-05	0.000224	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GOT1—liver cancer	2.44e-05	0.000224	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MMP9—liver cancer	2.43e-05	0.000223	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CDKN1A—liver cancer	2.42e-05	0.000223	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PPARA—liver cancer	2.42e-05	0.000222	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MAPK8—liver cancer	2.37e-05	0.000217	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.36e-05	0.000217	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—AKT1—liver cancer	2.36e-05	0.000217	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ALDOB—liver cancer	2.36e-05	0.000216	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GLUL—liver cancer	2.35e-05	0.000216	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CPT1B—liver cancer	2.35e-05	0.000216	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—HPGDS—liver cancer	2.32e-05	0.000213	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.28e-05	0.00021	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NR1H4—liver cancer	2.27e-05	0.000208	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.25e-05	0.000207	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CRABP1—liver cancer	2.25e-05	0.000206	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PSMD10—liver cancer	2.25e-05	0.000206	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PSMA4—liver cancer	2.25e-05	0.000206	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTA3—liver cancer	2.23e-05	0.000205	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GSTP1—liver cancer	2.19e-05	0.000201	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GOT2—liver cancer	2.19e-05	0.000201	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—VEGFA—liver cancer	2.18e-05	0.000201	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—STAT3—liver cancer	2.16e-05	0.000199	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—HMOX1—liver cancer	2.16e-05	0.000199	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PIK3CG—liver cancer	2.07e-05	0.00019	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PSMA4—liver cancer	2.07e-05	0.00019	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PSMD10—liver cancer	2.07e-05	0.00019	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP2E1—liver cancer	2.05e-05	0.000189	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTA4—liver cancer	2.04e-05	0.000187	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.02e-05	0.000186	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GSTM1—liver cancer	2.01e-05	0.000185	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GOT2—liver cancer	2.01e-05	0.000185	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MYC—liver cancer	2.01e-05	0.000185	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—TGFB1—liver cancer	2e-05	0.000184	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PPARG—liver cancer	2e-05	0.000183	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.99e-05	0.000183	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTA2—liver cancer	1.99e-05	0.000183	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—HPGDS—liver cancer	1.96e-05	0.00018	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.95e-05	0.000179	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYCS—liver cancer	1.92e-05	0.000177	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTA1—liver cancer	1.92e-05	0.000176	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CYP1A1—liver cancer	1.91e-05	0.000175	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NAT2—liver cancer	1.9e-05	0.000174	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP2E1—liver cancer	1.89e-05	0.000174	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GOT1—liver cancer	1.89e-05	0.000173	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GGT1—liver cancer	1.89e-05	0.000173	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—KRAS—liver cancer	1.86e-05	0.000171	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PIK3CD—liver cancer	1.82e-05	0.000167	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ALDOB—liver cancer	1.82e-05	0.000167	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—ALB—liver cancer	1.8e-05	0.000165	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—MTHFR—liver cancer	1.78e-05	0.000164	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.78e-05	0.000163	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYCS—liver cancer	1.77e-05	0.000162	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.76e-05	0.000161	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PSMA4—liver cancer	1.75e-05	0.000161	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PSMD10—liver cancer	1.75e-05	0.000161	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PPARA—liver cancer	1.75e-05	0.00016	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GGT1—liver cancer	1.74e-05	0.000159	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GOT1—liver cancer	1.74e-05	0.000159	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CRABP1—liver cancer	1.73e-05	0.000159	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PIK3CA—liver cancer	1.71e-05	0.000157	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GOT2—liver cancer	1.7e-05	0.000156	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTP1—liver cancer	1.69e-05	0.000156	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—HMOX1—liver cancer	1.67e-05	0.000154	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—TP53—liver cancer	1.65e-05	0.000152	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP2E1—liver cancer	1.6e-05	0.000147	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PIK3CB—liver cancer	1.59e-05	0.000146	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—HRAS—liver cancer	1.58e-05	0.000145	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTP1—liver cancer	1.56e-05	0.000143	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTM1—liver cancer	1.56e-05	0.000143	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.55e-05	0.000142	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—HMOX1—liver cancer	1.54e-05	0.000141	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—HPGDS—liver cancer	1.52e-05	0.000139	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—IL6—liver cancer	1.51e-05	0.000139	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYCS—liver cancer	1.5e-05	0.000138	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PIK3CG—liver cancer	1.5e-05	0.000137	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP1A1—liver cancer	1.48e-05	0.000136	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GGT1—liver cancer	1.47e-05	0.000135	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GOT1—liver cancer	1.47e-05	0.000135	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PPARG—liver cancer	1.44e-05	0.000133	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTM1—liver cancer	1.43e-05	0.000132	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—AKT1—liver cancer	1.39e-05	0.000128	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—MTHFR—liver cancer	1.38e-05	0.000126	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP1A1—liver cancer	1.36e-05	0.000125	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PSMA4—liver cancer	1.35e-05	0.000124	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PSMD10—liver cancer	1.35e-05	0.000124	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PPARA—liver cancer	1.35e-05	0.000124	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTP1—liver cancer	1.32e-05	0.000121	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PIK3CD—liver cancer	1.31e-05	0.000121	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GOT2—liver cancer	1.31e-05	0.000121	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—HMOX1—liver cancer	1.3e-05	0.00012	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ALB—liver cancer	1.3e-05	0.000119	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—MTHFR—liver cancer	1.27e-05	0.000116	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PPARA—liver cancer	1.24e-05	0.000114	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP2E1—liver cancer	1.24e-05	0.000113	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTM1—liver cancer	1.21e-05	0.000111	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.21e-05	0.000111	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PIK3CG—liver cancer	1.16e-05	0.000106	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYCS—liver cancer	1.16e-05	0.000106	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP1A1—liver cancer	1.15e-05	0.000106	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PIK3CB—liver cancer	1.15e-05	0.000105	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GGT1—liver cancer	1.13e-05	0.000104	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GOT1—liver cancer	1.13e-05	0.000104	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PPARG—liver cancer	1.12e-05	0.000103	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—MTHFR—liver cancer	1.07e-05	9.85e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PIK3CG—liver cancer	1.06e-05	9.77e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PPARA—liver cancer	1.05e-05	9.66e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PPARG—liver cancer	1.03e-05	9.43e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTP1—liver cancer	1.02e-05	9.36e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PIK3CD—liver cancer	1.02e-05	9.34e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—HMOX1—liver cancer	1.01e-05	9.23e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ALB—liver cancer	1e-05	9.22e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PIK3CA—liver cancer	9.67e-06	8.88e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	9.45e-06	8.68e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTM1—liver cancer	9.37e-06	8.6e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PIK3CD—liver cancer	9.35e-06	8.59e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ALB—liver cancer	9.23e-06	8.48e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PIK3CG—liver cancer	9.01e-06	8.28e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP1A1—liver cancer	8.88e-06	8.15e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PIK3CB—liver cancer	8.86e-06	8.14e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PPARG—liver cancer	8.7e-06	7.99e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—MTHFR—liver cancer	8.28e-06	7.6e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PIK3CB—liver cancer	8.15e-06	7.49e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PPARA—liver cancer	8.12e-06	7.46e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PIK3CD—liver cancer	7.92e-06	7.27e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—AKT1—liver cancer	7.9e-06	7.25e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ALB—liver cancer	7.82e-06	7.18e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PIK3CA—liver cancer	6.99e-06	6.42e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PIK3CG—liver cancer	6.95e-06	6.39e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PIK3CB—liver cancer	6.9e-06	6.34e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PPARG—liver cancer	6.71e-06	6.16e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PIK3CD—liver cancer	6.11e-06	5.61e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ALB—liver cancer	6.03e-06	5.54e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—AKT1—liver cancer	5.71e-06	5.24e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PIK3CA—liver cancer	5.4e-06	4.96e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PIK3CB—liver cancer	5.33e-06	4.89e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PIK3CA—liver cancer	4.97e-06	4.56e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—AKT1—liver cancer	4.41e-06	4.05e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PIK3CA—liver cancer	4.21e-06	3.87e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—AKT1—liver cancer	4.06e-06	3.73e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—AKT1—liver cancer	3.44e-06	3.16e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PIK3CA—liver cancer	3.25e-06	2.98e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—AKT1—liver cancer	2.65e-06	2.44e-05	CbGpPWpGaD
